JP2015036368A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015036368A5 JP2015036368A5 JP2013167198A JP2013167198A JP2015036368A5 JP 2015036368 A5 JP2015036368 A5 JP 2015036368A5 JP 2013167198 A JP2013167198 A JP 2013167198A JP 2013167198 A JP2013167198 A JP 2013167198A JP 2015036368 A5 JP2015036368 A5 JP 2015036368A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- estrogen
- dodecenyl
- testosterone secretion
- dodecenyl acetate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 claims description 24
- MAAMIILYYYQTQW-OUKQBFOZSA-N [(e)-dodec-1-enyl] acetate Chemical compound CCCCCCCCCC\C=C\OC(C)=O MAAMIILYYYQTQW-OUKQBFOZSA-N 0.000 claims description 12
- 229940011871 estrogen Drugs 0.000 claims description 12
- 239000000262 estrogen Substances 0.000 claims description 12
- 229960003604 testosterone Drugs 0.000 claims description 12
- 230000028327 secretion Effects 0.000 claims description 11
- 230000002708 enhancing effect Effects 0.000 claims description 9
- 239000004480 active ingredient Substances 0.000 claims description 4
- 239000003205 fragrance Substances 0.000 claims description 3
- 229930014626 natural product Natural products 0.000 claims description 3
- 210000004556 brain Anatomy 0.000 claims description 2
- 210000000196 olfactory nerve Anatomy 0.000 claims description 2
- YWWVWXASSLXJHU-AATRIKPKSA-N (9E)-tetradecenoic acid Chemical compound CCCC\C=C\CCCCCCCC(O)=O YWWVWXASSLXJHU-AATRIKPKSA-N 0.000 description 1
- MUZGQHWTRUVFLG-SREVYHEPSA-N 7Z-Dodecenyl acetate Chemical compound CCCC\C=C/CCCCCCOC(C)=O MUZGQHWTRUVFLG-SREVYHEPSA-N 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013167198A JP5923469B2 (ja) | 2013-08-10 | 2013-08-10 | エストロジェン及びテストステロン分泌増進用組成物、及びその芳香用組成物、並びにその芳香用具。 |
| PCT/JP2014/068676 WO2015022831A1 (ja) | 2013-08-10 | 2014-07-14 | エストロジェン及びテストステロン分泌増進用組成物、及びその芳香用組成物、並びにその芳香用具 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013167198A JP5923469B2 (ja) | 2013-08-10 | 2013-08-10 | エストロジェン及びテストステロン分泌増進用組成物、及びその芳香用組成物、並びにその芳香用具。 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015036368A JP2015036368A (ja) | 2015-02-23 |
| JP2015036368A5 true JP2015036368A5 (enExample) | 2015-06-25 |
| JP5923469B2 JP5923469B2 (ja) | 2016-05-24 |
Family
ID=52468221
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013167198A Expired - Fee Related JP5923469B2 (ja) | 2013-08-10 | 2013-08-10 | エストロジェン及びテストステロン分泌増進用組成物、及びその芳香用組成物、並びにその芳香用具。 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP5923469B2 (enExample) |
| WO (1) | WO2015022831A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2020007261A (ja) * | 2018-07-06 | 2020-01-16 | 株式会社マザー＆チャイルド | 女性用のテストステロン分泌を増進させるテストステロン分泌増進用組成物、芳香治療用組成物、芳香治療用入浴剤、芳香治療用食品、及び、芳香治療用具 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0923908A2 (pt) * | 2008-12-30 | 2015-08-04 | Basf Se | Dispensador para feromônios, e, processo para produzir um dispensador. |
-
2013
- 2013-08-10 JP JP2013167198A patent/JP5923469B2/ja not_active Expired - Fee Related
-
2014
- 2014-07-14 WO PCT/JP2014/068676 patent/WO2015022831A1/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201810985XA (en) | Tofacitinib oral sustained release dosage forms | |
| NZ712350A (en) | Abiraterone acetate formulation | |
| MX2016016593A (es) | Nuevos derivados de aminoalquibenzotiazepina y usos de los mismos. | |
| EA201591537A1 (ru) | Производные бензотиофена и композиции, их содержащие, в качестве селективных супрессоров эстрогеновых рецепторов | |
| CA2917096C (en) | Sulfoximine substituted 5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives and their use as cdk9 kinase inhibitors | |
| MD20170048A2 (ro) | Formulare pe bază de acetat de abirateronă şi procedee de utilizare a acesteia | |
| MX2016005668A (es) | Formas cristalinas de compuestos terapeuticos y sus usos. | |
| MX2015012435A (es) | Derivados de 3-fenilpropilamina sustituidos para el tratamiento de enfermedades y trastornos oftalmicos. | |
| PH12015501096A1 (en) | Composition for immediate and extended release | |
| NZ710291A (en) | 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions | |
| PH12017500810A1 (en) | Substituted 2,4 diamino-quinoline as new anticancer agents | |
| MX2015012111A (es) | Moduladores de ship1 y métodos relacionados con éstos. | |
| WO2015092810A3 (en) | Amorphous form of idelalisib | |
| MX363530B (es) | Compuesto de benzoxaborol tricíclico, método de preparación y uso del mismo. | |
| MD20150053A2 (ro) | Produs de comicronizare cu conţinut de acetat de ulipristal | |
| MX2021006070A (es) | Formulaciones oculares para la administracion de farmacos y proteccion del segmento anterior del ojo. | |
| UA117154C2 (uk) | Антагоністи s1p3 | |
| MX2016001422A (es) | Composicion farmaceutica de fingolimod. | |
| MX2015008733A (es) | Derivados de 1,2,3-triazol-4-amina para el tratamiento de enfermedades y transtornos relacionados con receptores sigma. | |
| IN2013MU01177A (enExample) | ||
| MX2015004314A (es) | Formulacion de aroma y fragancia (iii). | |
| JP2015036368A5 (enExample) | ||
| MX2015004312A (es) | Formulacion de aroma y fragancia (i). | |
| JP2015036367A5 (enExample) | ||
| TN2015000524A1 (en) | Pharmaceutical compositions |